1. Home
  2. IMRN vs EDUC Comparison

IMRN vs EDUC Comparison

Compare IMRN & EDUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • EDUC
  • Stock Information
  • Founded
  • IMRN 1994
  • EDUC 1965
  • Country
  • IMRN Australia
  • EDUC United States
  • Employees
  • IMRN N/A
  • EDUC N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • EDUC Consumer Specialties
  • Sector
  • IMRN Health Care
  • EDUC Consumer Discretionary
  • Exchange
  • IMRN Nasdaq
  • EDUC Nasdaq
  • Market Cap
  • IMRN 15.0M
  • EDUC 15.3M
  • IPO Year
  • IMRN N/A
  • EDUC N/A
  • Fundamental
  • Price
  • IMRN $2.11
  • EDUC $1.73
  • Analyst Decision
  • IMRN Strong Buy
  • EDUC
  • Analyst Count
  • IMRN 1
  • EDUC 0
  • Target Price
  • IMRN $5.00
  • EDUC N/A
  • AVG Volume (30 Days)
  • IMRN 6.2K
  • EDUC 15.3K
  • Earning Date
  • IMRN 12-31-2024
  • EDUC 01-13-2025
  • Dividend Yield
  • IMRN N/A
  • EDUC N/A
  • EPS Growth
  • IMRN N/A
  • EDUC N/A
  • EPS
  • IMRN N/A
  • EDUC N/A
  • Revenue
  • IMRN $3,271,194.00
  • EDUC $42,415,800.00
  • Revenue This Year
  • IMRN N/A
  • EDUC N/A
  • Revenue Next Year
  • IMRN N/A
  • EDUC N/A
  • P/E Ratio
  • IMRN N/A
  • EDUC N/A
  • Revenue Growth
  • IMRN 171.67
  • EDUC N/A
  • 52 Week Low
  • IMRN $1.59
  • EDUC $0.87
  • 52 Week High
  • IMRN $5.96
  • EDUC $2.95
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 52.87
  • EDUC 29.98
  • Support Level
  • IMRN $2.05
  • EDUC $1.59
  • Resistance Level
  • IMRN $2.23
  • EDUC $1.94
  • Average True Range (ATR)
  • IMRN 0.16
  • EDUC 0.13
  • MACD
  • IMRN 0.02
  • EDUC -0.02
  • Stochastic Oscillator
  • IMRN 47.06
  • EDUC 21.05

About IMRN Immuron Limited

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About EDUC Educational Development Corporation

Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.

Share on Social Networks: